Jeonghwan Youk

1.9k total citations
40 papers, 506 citations indexed

About

Jeonghwan Youk is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Jeonghwan Youk has authored 40 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Molecular Biology and 11 papers in Hematology. Recurrent topics in Jeonghwan Youk's work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Jeonghwan Youk is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Jeonghwan Youk collaborates with scholars based in South Korea, United States and Ethiopia. Jeonghwan Youk's co-authors include Young Seok Ju, Jake June-Koo Lee, Inho Kim, Kijong Yi, Yohan An, Sung‐Soo Yoon, Yoon Kyung Jeon, Seongyeol Park, Tae Min Kim and Junehawk Lee and has published in prestigious journals such as Nature, Cell and Blood.

In The Last Decade

Jeonghwan Youk

33 papers receiving 504 citations

Peers

Jeonghwan Youk
Anand Pathak United States
Alexis Norris-Kirby United States
Chin Hin Ng Singapore
Nora Ku United States
Kijong Yi South Korea
Kyeong‐Man Hong South Korea
Shona Pendse United States
C-C. Lin Taiwan
Jeonghwan Youk
Citations per year, relative to Jeonghwan Youk Jeonghwan Youk (= 1×) peers Takeshi Isoyama

Countries citing papers authored by Jeonghwan Youk

Since Specialization
Citations

This map shows the geographic impact of Jeonghwan Youk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeonghwan Youk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeonghwan Youk more than expected).

Fields of papers citing papers by Jeonghwan Youk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeonghwan Youk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeonghwan Youk. The network helps show where Jeonghwan Youk may publish in the future.

Co-authorship network of co-authors of Jeonghwan Youk

This figure shows the co-authorship network connecting the top 25 collaborators of Jeonghwan Youk. A scholar is included among the top collaborators of Jeonghwan Youk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeonghwan Youk. Jeonghwan Youk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Park, Changhee, Rathana Kim, Jae Moon Bae, et al.. (2025). Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications. ESMO Open. 10(1). 104097–104097. 1 indexed citations
3.
Kim, Soo-Min, Jaemoon Koh, Tae Min Kim, et al.. (2025). Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer. iScience. 28(2). 111736–111736. 3 indexed citations
4.
Lim, Yoojoo, Chan‐Young Ock, Jeonghwan Youk, et al.. (2025). Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma. Journal of Thoracic Disease. 17(7). 4409–4419.
5.
Youk, Jeonghwan, Yoojoo Lim, Hwang‐Phill Kim, et al.. (2024). Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non–Small Cell Lung Cancer. Cancer Research and Treatment. 56(3). 765–773. 5 indexed citations
6.
Koh, Jaemoon, Tae Min Kim, Jeonghwan Youk, et al.. (2024). Transcriptomic Heterogeneity of EGFR -Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer. Clinical Cancer Research. 30(20). 4729–4742. 5 indexed citations
7.
Youk, Jeonghwan, Ja Min Byun, Youngil Koh, et al.. (2023). Effects of tertiary palliative care on the pattern of end‐of‐life care in patients with hematologic malignancies in Korea. European Journal Of Haematology. 112(5). 743–755. 6 indexed citations
8.
Youk, Jeonghwan, Jeong Yeon Kim, Jung Woo Park, et al.. (2023). Widespread somatic L1 retrotransposition in normal colorectal epithelium. Nature. 617(7961). 540–547. 26 indexed citations
10.
Kim, Yong Joon, Jeonghwan Youk, Jung Woo Han, et al.. (2023). Subset of retinoblastoma tumours is associated withBRCA1/2mutations. British Journal of Ophthalmology. 108(7). 1011–1017.
12.
Chung, Sung Won, Yun Bin Lee, Min Kyung Park, et al.. (2023). Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma. Clinical and Molecular Hepatology. 29(3). 794–809.
13.
Ahn, Hyun Jin, Ja Min Byun, Inho Kim, et al.. (2022). Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients. Journal of Korean Medical Science. 37(6). e48–e48. 3 indexed citations
14.
Yi, Kijong, et al.. (2021). Mutational spectrum of SARS-CoV-2 during the global pandemic. Experimental & Molecular Medicine. 53(8). 1229–1237. 32 indexed citations
15.
Park, Hyunkyung, Jeonghwan Youk, Dong‐Yeop Shin, et al.. (2019). Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy. BMC Cancer. 19(1). 358–358. 14 indexed citations
16.
Park, Hyunkyung, Ji‐Won Kim, Jeonghwan Youk, et al.. (2018). Serum Free Light Chain Difference and β2 Microglobulin Levels Are Risk Factors for Thromboembolic Events in Patients With AL Amyloidosis. Clinical Lymphoma Myeloma & Leukemia. 18(6). 408–414. 10 indexed citations
17.
Park, Hyunkyung, Jeonghwan Youk, Wan Beom Park, et al.. (2017). Mycafungin Prophylaxis for Adult Acute Leukemia Patients Undergoing Induction Chemotherapy. Blood. 130. 5033–5033.
18.
Park, Hyunkyung, Jeonghwan Youk, Inho Kim, et al.. (2016). Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia. Annals of Hematology. 95(11). 1777–1786. 23 indexed citations
19.
Youk, Jeonghwan, Young‐Il Koh, Ji‐Won Kim, et al.. (2016). A scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data. Blood Research. 51(1). 17–17. 3 indexed citations
20.
Lee, Jake June-Koo, Sandra Louzada, Yu An, et al.. (2016). Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Annals of Oncology. 28(4). 890–897. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026